NO331686B1 - Fremgangsmate for a fremstille bionedbrytbare mikrokuler som inneholder et anticancermiddel og er belagt med en polymer, suspensjoninneholdende disse mikrokulene og anvendelse av mikrokulene ifremstilling av et medisinsk produkt til behandlingen av glioblastom. - Google Patents

Fremgangsmate for a fremstille bionedbrytbare mikrokuler som inneholder et anticancermiddel og er belagt med en polymer, suspensjoninneholdende disse mikrokulene og anvendelse av mikrokulene ifremstilling av et medisinsk produkt til behandlingen av glioblastom. Download PDF

Info

Publication number
NO331686B1
NO331686B1 NO20015501A NO20015501A NO331686B1 NO 331686 B1 NO331686 B1 NO 331686B1 NO 20015501 A NO20015501 A NO 20015501A NO 20015501 A NO20015501 A NO 20015501A NO 331686 B1 NO331686 B1 NO 331686B1
Authority
NO
Norway
Prior art keywords
microspheres
anticancer agent
polymer
suspension
weeks
Prior art date
Application number
NO20015501A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015501D0 (no
NO20015501L (no
Inventor
Nathalie Faisant
Jean-Pierre Benoit
Philippe Menei
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of NO20015501D0 publication Critical patent/NO20015501D0/no
Publication of NO20015501L publication Critical patent/NO20015501L/no
Publication of NO331686B1 publication Critical patent/NO331686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20015501A 1999-05-17 2001-11-09 Fremgangsmate for a fremstille bionedbrytbare mikrokuler som inneholder et anticancermiddel og er belagt med en polymer, suspensjoninneholdende disse mikrokulene og anvendelse av mikrokulene ifremstilling av et medisinsk produkt til behandlingen av glioblastom. NO331686B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906207A FR2793684B1 (fr) 1999-05-17 1999-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
PCT/FR2000/001315 WO2000069413A1 (fr) 1999-05-17 2000-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome

Publications (3)

Publication Number Publication Date
NO20015501D0 NO20015501D0 (no) 2001-11-09
NO20015501L NO20015501L (no) 2002-01-09
NO331686B1 true NO331686B1 (no) 2012-02-20

Family

ID=9545636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015501A NO331686B1 (no) 1999-05-17 2001-11-09 Fremgangsmate for a fremstille bionedbrytbare mikrokuler som inneholder et anticancermiddel og er belagt med en polymer, suspensjoninneholdende disse mikrokulene og anvendelse av mikrokulene ifremstilling av et medisinsk produkt til behandlingen av glioblastom.

Country Status (30)

Country Link
US (2) US6803052B2 (de)
EP (2) EP1053746B1 (de)
JP (1) JP5230045B2 (de)
KR (1) KR100649948B1 (de)
CN (1) CN1210020C (de)
AR (1) AR024008A1 (de)
AT (1) ATE228353T1 (de)
AU (1) AU775320B2 (de)
BG (1) BG64936B1 (de)
BR (1) BR0010648A (de)
CA (1) CA2388656C (de)
CZ (1) CZ20014137A3 (de)
DE (1) DE60000842T2 (de)
DK (1) DK1053746T3 (de)
EA (1) EA004943B1 (de)
ES (1) ES2185544T3 (de)
FR (1) FR2793684B1 (de)
HK (1) HK1047044B (de)
HU (1) HUP0201224A3 (de)
IL (2) IL146467A0 (de)
MX (1) MXPA01011919A (de)
NO (1) NO331686B1 (de)
NZ (1) NZ515515A (de)
PL (1) PL201614B1 (de)
PT (1) PT1053746E (de)
SI (1) SI1053746T1 (de)
SK (1) SK16342001A3 (de)
TW (1) TWI229608B (de)
WO (1) WO2000069413A1 (de)
ZA (1) ZA200109415B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001010489A2 (de) 1999-08-05 2001-02-15 MAP Medizintechnik für Arzt und Patient GmbH & Co. KG Vorrichtung zur zufuhr eines atemgases, befeuchtungsvorrichtung, atemgasschlauch und anschlussvorrichtung hierfür
AUPR098300A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
US20020081339A1 (en) * 2000-12-22 2002-06-27 Philippe Menei Treatment of inoperable tumors by stereotactic injection of microspheres
WO2002094321A1 (en) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions for promoting healing of bone fracture
WO2002094320A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Therapeutic compositions for repairing chondropathy
JP4490095B2 (ja) 2001-06-29 2010-06-23 メドグラフト マイクロテック インコーポレイテッド 生体分解性の注入可能な移植物およびそれに関連する製造方法ならびに使用方法
UA77999C2 (en) * 2001-12-10 2007-02-15 Thymosin-alpha 1 for treatment of malignant glioblastoma
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
NZ710686A (en) 2003-06-20 2017-02-24 Resmed Ltd Breathable gas apparatus with humidifier
WO2005023293A1 (en) * 2003-09-09 2005-03-17 Pohang University Of Science And Technology Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
WO2005089398A2 (en) * 2004-03-18 2005-09-29 St. Luke's Hospital Method for the delivery of sustained release agents
US8088413B2 (en) * 2004-04-16 2012-01-03 Nuvue Therapeutics, Inc. Methods for improved cryo-chemotherapy tissue ablation
WO2005099367A2 (en) 2004-04-16 2005-10-27 Critical Care Innovations, Inc. Systems and methods for improving image-guided tissue ablation
CN101052378A (zh) 2004-09-07 2007-10-10 生物相容英国有限公司 从栓塞剂送递药物
US8702580B2 (en) * 2004-10-06 2014-04-22 Brainlab Ag Method and device for assisting in a tissue treatment
CN100386115C (zh) * 2004-10-14 2008-05-07 孔庆忠 一种抗癌药物组合物
CN1299685C (zh) * 2005-01-26 2007-02-14 上海大学 氟尿嘧啶载药微球及其制备方法
CN100340297C (zh) * 2005-02-03 2007-10-03 山东蓝金生物工程有限公司 抗癌体内植入剂
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂
CN100464785C (zh) * 2005-08-30 2009-03-04 孔庆忠 一种抗癌药物缓释注射剂及其应用
CN1923282B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含激素类药物的抗癌缓释注射剂
CN100500214C (zh) * 2006-01-09 2009-06-17 济南帅华医药科技有限公司 抗癌药物缓释注射剂
CN100563711C (zh) * 2006-01-18 2009-12-02 济南帅华医药科技有限公司 一种抗癌缓释注射剂
CN100500215C (zh) * 2006-01-23 2009-06-17 济南帅华医药科技有限公司 含氨甲喋呤及其增效剂的缓释注射剂
CN100531715C (zh) * 2006-01-23 2009-08-26 济南帅华医药科技有限公司 氨甲喋呤缓释注射剂
CN100531717C (zh) * 2006-01-23 2009-08-26 济南帅华医药科技有限公司 含氨甲喋呤增效剂的抗癌缓释剂
CN1923173B (zh) * 2006-02-24 2010-05-19 济南康泉医药科技有限公司 一种同载抗癌抗生素及其增效剂的抗癌药物缓释剂
CN100486560C (zh) * 2006-03-06 2009-05-13 济南康泉医药科技有限公司 一种含血管抑制剂的复方抗癌缓释注射剂
US20090036380A1 (en) * 2006-03-14 2009-02-05 Yeda Research And Development Co., Ltd. Composition And Method For Brain Tumor Therapy
CN100464736C (zh) * 2006-03-17 2009-03-04 山东蓝金生物工程有限公司 同载抗代谢药物及其增效剂的抗癌缓释注射剂
EP1985286A1 (de) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Mikrokügelchen zur Behandlung von Gehirntumoren
KR20140102294A (ko) 2011-12-13 2014-08-21 엔진아이씨 몰레큘러 딜리버리 피티와이 리미티드 뇌 종양에 대한 치료제의 전달을 위한 박테리아 유래된, 무손상 미니세포
US10342769B2 (en) 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
WO2017083717A1 (en) * 2015-11-11 2017-05-18 Qrono, Inc. Sustained release pharmaceutical compositions and methods of use
HUE066356T2 (hu) 2017-08-24 2024-07-28 Novo Nordisk As GLP-1 készítmények és alkalmazásaik
BR112022010952A2 (pt) 2019-12-05 2022-09-06 West Virginia Univ Board Of Governors On Behalf Of West Virginia Univ Nanosferas de plga carregadas de proteína
PE20221575A1 (es) 2020-02-18 2022-10-06 Novo Nordisk As Formulaciones farmaceuticas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
ATE258804T1 (de) * 1996-10-16 2004-02-15 Regeneron Pharma Verfahren zur verabreichung von wachstumsfaktoren
DE69839508D1 (de) * 1997-03-31 2008-07-03 Toray Industries Chinolinmorphinan-derivate und ihre medizinische anwendung
EP1028735A4 (de) * 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc Therapeutische methode die die verwendung eines neuroregulins beinhalted

Also Published As

Publication number Publication date
PL352372A1 (en) 2003-08-25
US6803052B2 (en) 2004-10-12
BG106106A (en) 2002-05-31
US20020051749A1 (en) 2002-05-02
IL146467A (en) 2006-06-11
HUP0201224A2 (hu) 2002-11-28
CN1356892A (zh) 2002-07-03
EP1053746B1 (de) 2002-11-27
HK1047044A1 (en) 2003-02-07
DE60000842T2 (de) 2003-08-28
SI1053746T1 (en) 2003-04-30
NO20015501D0 (no) 2001-11-09
EP1228755A1 (de) 2002-08-07
ES2185544T3 (es) 2003-05-01
AU775320B2 (en) 2004-07-29
US7041241B2 (en) 2006-05-09
US20030175356A1 (en) 2003-09-18
FR2793684B1 (fr) 2001-08-10
MXPA01011919A (es) 2002-05-06
BG64936B1 (bg) 2006-10-31
KR20020000178A (ko) 2002-01-04
EA200101206A1 (ru) 2002-04-25
AR024008A1 (es) 2002-09-04
PT1053746E (pt) 2003-04-30
WO2000069413A1 (fr) 2000-11-23
JP2002544219A (ja) 2002-12-24
HUP0201224A3 (en) 2004-05-28
FR2793684A1 (fr) 2000-11-24
ZA200109415B (en) 2003-01-29
EP1053746A1 (de) 2000-11-22
PL201614B1 (pl) 2009-04-30
IL146467A0 (en) 2002-07-25
SK16342001A3 (sk) 2002-08-06
HK1047044B (zh) 2005-12-23
NZ515515A (en) 2004-02-27
CN1210020C (zh) 2005-07-13
AU4764100A (en) 2000-12-05
JP5230045B2 (ja) 2013-07-10
NO20015501L (no) 2002-01-09
KR100649948B1 (ko) 2006-11-24
TWI229608B (en) 2005-03-21
CA2388656A1 (fr) 2000-11-23
CA2388656C (fr) 2011-04-26
EA004943B1 (ru) 2004-10-28
BR0010648A (pt) 2002-02-19
ATE228353T1 (de) 2002-12-15
DE60000842D1 (de) 2003-01-09
CZ20014137A3 (cs) 2002-06-12
DK1053746T3 (da) 2003-03-31

Similar Documents

Publication Publication Date Title
US6803052B2 (en) Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
EP2394664B1 (de) Zusammensetzungen für injizierbare, in-situ biologisch abbaubare Implantate
ES2950857T3 (es) Métodos para la preparación de composiciones de depósito inyectables
US20040180095A1 (en) Treatment of inoperable turmors by stereotactic injection of microspheres
EP4475817A1 (de) Mikrokügelchen zur verlängerten freisetzung von fenofibrat
US8895597B2 (en) Combination of local temozolomide with local BCNU
WO2001010416A1 (en) Method of delivering a chemotherapeutic agent to a solid tumor
ES2900171T3 (es) Composición inyectable
KR20240056731A (ko) 항정신병 주사용 서방형 조성물
Mirajkar et al. FORMULATION OF AN INSITU FORMING INJECTABLE SUSTAINED RELEASE SPONGE OF GRANISETRON HYDROCHLORIDE
CN101336898A (zh) 同载铂类药物及其增效剂的抗癌缓释剂
CN101371820A (zh) 含氨甲喋呤增效剂的抗癌缓释剂

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees